Created an experimental vaccine against Ebola virus, reported according to the study, published in the journal The Lancet on Thursday. The vaccine gives hope for a better protection from diseases that ravaged West Africa in 2014 and killed over 11 thousand people.
"Ebola has left a devastating legacy in the country. We are proud that we were able to contribute to the development of a vaccine," said Dr. Keith Sakaba, Director of the National Agency for health issues in Guinea. The experimental vaccine was developed in 2015 for people in Guinea who were in contact with patients who have recently confirmed cases of Ebola. A few months after the start of the test, the world health organization announced that preliminary results were "extremely encouraging development."
A total of 5,837 people received the vaccine rVSV-ZEBOV, and neither had registered a case of Ebola after 10 days or longer, the study said. Among people who have not received the vaccine were registered 23 cases of infection. Some people who received the vaccine reported headaches, fatigue and muscle pain. Two patients had serious reactions including those who have an allergic reaction. Ebola was first discovered in 1976. The fever usually hits isolated African communities. These flashes were easy to extinguish, but in 2014, the virus had reached the city, spreading like wildfire and caught the global health community by surprise.
Ebola is very contagious. To combat the infection, researchers gave the vaccine to the so-called "clusters" or "ring" - the group of people who were in contact with the Ebola patient. This is the same strategy that was used to eradicate smallpox.
sections: Society, World News |